Le Tree Forms Medical Aesthetics Joint Venture With Jingxin Meiye in China

• Le Tree Holdings completed incorporation of a Chinese joint venture with Xiamen Jingxin Meiye Technology on October 27, 2026.
• The venture, Xiamen Jingzi International Medical Aesthetics Management, has registered capital of RMB 2 million.
• Wholly owned subsidiary LeTree (Xiamen) Commercial Management holds 70%, with its RMB 1.4 million contribution funded from internal resources.
• Jingxin Meiye holds 30% for RMB 600,000; both partners must contribute cash within 30 days of incorporation.
• The venture’s principal activities include medical aesthetics, health management services and supply chain operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Le Tree Holdings Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: Z42M8VXQ1NCRN3YM) on October 27, 2026, and is solely responsible for the information contained therein.